On December 2nd 2006, Pfizer announced that it had stopped all development and clinical trials for its cholesterol drug Torcetrapib. Torcetrapib was widely regarded as […]
Pfizer Plans To Eliminate 10,000 Jobs, Close 3 Manufacturing Plants and 5 R&D Sites Read More »
By Daniel R. Matlis No, it is not a typo. If you are uninsured, that $4 prescription will probably cost you $1,053. Why so much
That will be 1,053 Dollars for your 4 Dollar prescription Read More »
By Daniel R. Matlis No, it’s not what you think; I’m not going “pro” this or “anti” that on you. I am referring to the
My Body, My Choice? Read More »
Last week, Dr. Andrew von Eschenbach was confirmed by the Senate to head the U.S. Food and Drug Administration. Dr. von Eschenbach is 65-year-old oncologist,
Senate Confirms von Eschenbach as FDA Commissioner Read More »
Source: CNBC/The Wall Street Journal Jim Greenwood, president of the Biotechnology Industry Organization, discusses the impact of the election on the Biotechnology Industry in general and stem-cell
The Election's Impact on the Biotech Industry Read More »
BioSP supports the development of Life-Science Companies in the Tri State region (PA, NJ, DE) FOR IMMEDIATE RELEASE CONTACT: Monica Malave Director, Marketing & Communications
Bio Strategy Partners Adds Axendia to Member Roster Read More »
by Leslie Gladstone Restaino The explosion of Life sciences innovation and the globalization of the marketplace have heightened the importance of intel1ectual property (IP) in
Understanding Your Patent Portfolio, Reducing Risk Through Due Diligence Read More »
FOR IMMEDIATE RELEASE Contact: Monica Malave Director, Marketing & Communications mmalave@axendia.com Yardley, PA, October 24, 2006 — Axendia, a trusted advisor to
Axendia Joins Forces with Microsoft to Strengthen BioIT Alliance Read More »
On February 26, 2004, the FDA published its final rule on “Bar Code Label Requirements for Human Drug Products and Biological Products”. According to the
A Bar-Code In The Hand Is Worth Two RFID Tags In The Bush Read More »
By Daniel R. Matlis According to a recent study by the Milken Institute the life sciences industry is an emerging powerhouse for U.S. global
Life Sciences Industry is an Emerging Powerhouse in Pennsylvania Read More »
The U.S. Food and Drug Administration (FDA) yesterday approved the AbioCor®, the world’s first completely self-contained, implantable Replacement Heart. This approval provides patients suffering from
FDA Approves First Implantable Replacement Heart Read More »
By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
